RSV Pharmacy Expansion (London)

NHS England (London Region) invites suitable and qualified Pharmacies to submit their interest and completed Invitation to Tender (ITT) submissions for the delivery of RSV Expansion Services. Outline Successful Suppliers will be commissioned via a CP ES which will be of the type referred to in direction 14 of the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 as amended.

Details of the Enhanced Service requirements will be set out in an ES specification which cannot be altered locally. Successful Suppliers will provide the Services in accordance with the terms of the CP ES and in full compliance with their Terms of Service or Local Pharmaceutical Services contract terms, as applicable.

This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023.

For the avoidance of doubt the provisions of the Public Contract Regulations 2015 does not apply to this award. The Procurement is being managed by the NHS London Commercial Hub (NHS LCH) hosted by NEL ICB, on behalf of the Authority, in connection with a competitive Invitation to Tender (ITT) exercise that is being conducted via a competitive process under the Health Care Services (Provider Selection Regime) Regulations 2023.

The purpose of this procurement is to engage provider's offering a suitable pharmaceutical Service to support RSV expansion within the London region. Further detail can be found within the ITT documents.

The contract term will be 18 months with the option to extend for a further 2 years at the sole discretion of the Authority. The contract will start in September 2025 and end 31/03/2027 with an optional extension for a further two years The lifetime value of the contract is undetermined due to its service based requirement.

The purpose of this procurement is to engage provider's offering a suitable pharmaceutical Service to support RSV expansion within the London region. Further detail can be found within the ITT documents.

The contract term will be 18 months with the option to extend for a further 2 years at the sole discretion of the Authority. The contract will start in September 2025 and end 31/03/2027 with an optional extension for a further two years The lifetime value of the contract is undetermined due to its service based requirement.

The purpose of this procurement is to engage provider's offering a suitable pharmaceutical Service to support RSV expansion within the London region. Further detail can be found within the ITT documents.

The contract term will be 18 months with the option to extend for a further 2 years at the sole discretion of the Authority. The contract will start in September 2025 and end 31/03/2027 with an optional extension for a further two years The lifetime value of the contract is undetermined due to its service based requirement.

The purpose of this procurement is to engage provider's offering a suitable pharmaceutical Service to support RSV expansion within the London region. Further detail can be found within the ITT documents.

The contract term will be 18 months with the option to extend for a further 2 years at the sole discretion of the Authority. The contract will start in September 2025 and end 31/03/2027 with an optional extension for a further two years The lifetime value of the contract is undetermined due to its service based requirement.